NanoEcho’s CEO and Clinical Director share more about the successfully completed study
NanoEcho’s clinical dose confirmation study has achieved its primary objectives according to the study’s design. This is a crucial milestone, indicating that the study has established an appropriate dose of the nanoparticle NEP-1 (ferumoxtran) as well as the time interval for the subsequent imaging examination. The study is the first clinical trial with NanoEcho’s imaging […]
CEO Linda Persson comments: Health-economic analysis of NanoEcho’s diagnostics accepted for publication in a leading journal
NanoEcho’s diagnostics have the potential to improve patients’ quality of life and reduce healthcare costs – now confirmed in a scientific article accepted for publication in the highly regarded journal PharmacoEconomics! The authors, including experts from IHE, the Institute for Health Economics, doctors from Skåne University Hospital, and representatives from NanoEcho, demonstrate in their analysis […]
CEO Linda Persson summarises 2024
Today, NanoEcho has published its Annual Report for 2024, a year of significant progress for NanoEcho! We have taken the crucial step from development to clinical phase, while also becoming a publicly listed company – milestones that strengthen our path towards commercialisation. In 2025, we will continue our clinical programme and take important steps towards […]
Interview with Ann-Christin Malmborg Hager – Board Member at NanoEcho
Meet Ann-Christin Malmborg Hager – an experienced board member with a strong background in transforming academic innovations into successful companies! With over 25 years of experience in developing companies based on academic ideas, Ann-Christin brings valuable strategic insight and business expertise. “NanoEcho addresses a significant medical need,” says Ann-Christin. “Imagine being diagnosed with rectal cancer and having […]
CEO Linda Persson Summarises the Fourth Quarter
Watch CEO Linda Persson summarise the fourth quarter, with a primary focus on the clinical study that started in October. Just before the end of the year, we were able to report that the study is progressing as planned and that half of the twelve planned participants have completed the study protocol. “For the first […]
CEO interview with Kalqyl – What makes NanoEcho an interesting investment?
What makes NanoEcho an interesting investment? The answer is revealed when Kalqyl interviews CEO Linda Persson about NanoEcho’s ongoing rights issue! In an engaging discussion, we also learn more about the global need NanoEcho aims to address, why current diagnostic methods for early rectal cancer are insufficient, and how NanoEcho’s technology could potentially change the […]
Finance blogger “Miljonär innan 30” interviews CEO Linda Persson
In connection with the ongoing rights issue, finance blogger “Miljonär innan 30” has interviewed NanoEcho’s CEO, Linda Persson. The interview covers key topics regarding the company’s future, including when the documentation for market approval is planned to be submitted to the authorities, which markets will be prioritised ahead of the upcoming market launch, and what […]
Meet Åke Bengtsson – board member at NanoEcho
Meet Åke Bengtsson – the board member with valuable global experience from the industry! Åke has extensive experience in the global manufacturing industry, and his insights are highly valuable in NanoEcho’s journey toward becoming an operational company in an international market. “The team and our partners are our greatest strength,” says Åke, highlighting the impressive competence […]
NanoEcho Awarded “Nordic IPO of the Year 2024”
NanoEcho has been awarded the “Nordic IPO of the Year 2024” prize at a gala organised by Nordic Listed Leaders (NLL) in Helsinki, Finland. NLL is a newly established network aimed at connecting and empowering leaders from publicly listed companies across the Nordic region. The award recognises companies whose market listings contribute innovative solutions and […]
NanoEcho Successfully Completes the 10XHealth Business Development Programme
Today, NanoEcho has successfully completed the 10XHealth Life Science Scale-Up business development programme, developed by SmiLe Venture Hub and Medicon Village. NanoEcho was one of seven selected companies given the opportunity to participate in the programme free of charge. Over the past year, the programme has focused on key areas such as entrepreneurship, financing, internationalisation, […]
